(NASDAQ:TRIB) DUBLIN, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has received written notice from the Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with the $1.00 per share minimum bid price requirement pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”) and the minimum market value of publicly held shares (“MVPHS”) requirement under Nasdaq Listing Rule 5450(b)(2)(C) (the “MVPHS Requirement”).
Related Questions
How will the regained compliance affect TRIB's share liquidity and price volatility?
What is the likelihood that TRIB will maintain the $1.00 bid price and MVPHS thresholds in the coming quarters?
Are there any upcoming catalysts or earnings releases that could further influence the stock after this compliance announcement?